首页> 外文期刊>Scientific reports. >Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC)
【24h】

Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC)

机译:人肝癌干细胞病理学癌症MIRNA和转录因子的共调控网络(HCSC)

获取原文
           

摘要

Hepatic cancer stem cells (HCSCs) are considered as main players for the hepatocellular carcinoma (HCC) initiation, metastasis, drug resistance and recurrence. There is a growing evidence supporting the down-regulated miRNAs in HCSCs as key suppressors for the stemness traits, but still more details are vague about how these miRNAs modulate the HCC development. To uncover some of these miRNA regulatory aspects in HCSC, we compiled 15 down-regulated miRNA and their validated and predicted up-regulated targets in HCSC. The targets were enriched for several cancer cell stemness hallmarks and CSC pre-metastatic niche, which support these miRNAs role in suppression of HCSCs neoplastic transformation. Further, we constructed miRNA-Transcription factor (TF) regulatory networks, which provided new insights on the role of the proposed miRNA-TF co-regulation in the cancer stemness axis and its cross talk with the surrounding microenvironment. Our analysis revealed HCSC important hubs as candidate regulators for targeting hepatic cancer stemness such as, miR-148a, miR-214, E2F family, MYC and SLC7A5. Finally, we proposed a possible model for miRNA and TF co-regulation of HCSC signaling pathways. Our study identified an HCSC signature and set bridges between the reported results to give guide for future validation of HCC therapeutic strategies avoiding drug resistance.
机译:肝癌干细胞(HCSCs)被认为是肝细胞癌(HCC)起始,转移,耐药性和复发的主要参与者。存在越来越多的证据,支持HCSC中的下调miRNA作为茎干性状的关键抑制器,但仍然更多细节对于这些miRNA如何调节HCC开发而言,仍然是模糊的。为了揭示HCSC中的一些MiRNA调节方面,我们编制了15个下调的miRNA及其在HCSC中的验证和预测的上调靶标。富集的靶标富集了几种癌细胞茎标志和CSC预转移性Niche,其支持这些miRNA在抑制HCSCs肿瘤转化中的作用。此外,我们构建了miRNA转录因子(TF)监管网络,该网络提供了关于提出的miRNA-TF共调节在癌症茎秆轴上的作用及其与周围微环境的交叉谈话的作用的新见解。我们的分析揭示了HCSC重要中心作为候选肝癌茎的候选调节剂,例如miR-148a,miR-214,E2f家族,Myc和Slc7a5。最后,我们提出了MiRNA和TF的Chsc信号传导途径的CORNA和TF共调整的可能模型。我们的研究确定了一个HCSC签名,并在据报道的结果之间设定了桥梁,以便向未来验证HCC治疗策略避免耐药性的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号